Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.
D000632:Aminopyrine / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001168:Arthritis / Q000517:prevention & control; D001241:Aspirin / Q000627:therapeutic use; D002351:Carrageenan / Q000037:antagonists & inhibitors; D003061:Codeine / Q000627:therapeutic use; D003864:Depression, Chemical; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004357:Drug Synergism; D004487:Edema / Q000517:prevention & control*; D004558:Electric Stimulation; D005334:Fever / Q000188:drug therapy*; D000882:Haplorhini; D008297:Male; D051379:Mice; D009125:Muscle Relaxants, Central / Q000008:administration & dosage*; D010146:Pain / Q000188:drug therapy*; D010423:Pentazocine / Q000627:therapeutic use; D010424:Pentobarbital / Q000494:pharmacology; D010615:Phenacetin / Q000627:therapeutic use; D010648:Phenylacetates / Q000008:administration & dosage* / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013331:Strychnine / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000008:administration & dosage*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009125:Muscle Relaxants, Central; D010648:Phenylacetates; D014149:Tranquilizing Agents; D000632:Aminopyrine; D002351:Carrageenan; D010615:Phenacetin; D010653:Phenylbutazone; D013331:Strychnine; D010424:Pentobarbital; D001241:Aspirin; D010423:Pentazocine; D011431:Dextropropoxyphene; D003061:Codeine